Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca De Simone

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Ocular Immunology and Inflammation|April 2, 2026
Placoid Macular Lesion as an Atypical Presentation of Vitreoretinal Lymphoma Mimicking Autoimmune RetinopathyRocco Bruno, Fabrizio Gozzi, Emanuele Ragusa, et al.
American Journal of Ophthalmology|April 3, 2026
Unilateral Retinal Pigment Epithelium Dysgenesis (URPED) - The Expanded Spectrum and New Insights from Multimodal ImagingAndrea Trinco, Francesco Romano, Martina Matteucci, et al.
Chembiochem : a European Journal of Chemical Biology|March 31, 2025
Cold-Adapted Lipid A from Polaribacter sp. SM1127: A Study of Structural Heterogeneity and Immunostimulatory PropertiesRoberta Cirella, Emanuela Andretta, Luca De Simone Carone, et al.
Ocular Immunology and Inflammation|April 22, 2024
Anterior Vitreous Objective Assessment in Uveitis: An Anterior Segment Swept Source Optical Coherence Tomography StudyAlessandro Invernizzi, Chiara Zaffalon, Priscilla Manni, et al.
Ocular Immunology and Inflammation|October 6, 2020
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical FeaturesLuca De Simone, Alessandro Invernizzi, Raffaella Aldigeri, et al.
Ocular Immunology and Inflammation|April 1, 2021
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive TreatmentElena Bolletta, Fabrizio Gozzi, Valentina Mastrofilippo, et al.
Journal of Clinical Medicine|December 24, 2021
Uveitis and Other Ocular Complications Following COVID-19 VaccinationElena Bolletta, Danilo Iannetta, Valentina Mastrofilippo, et al.
American Journal of Ophthalmology|January 15, 2024
Immunomodulatory Treatment Versus Systemic Steroids in Inflammatory Choroidal Neovascularization Secondary to Idiopathic Multifocal ChoroiditisMatteo Airaldi, Davide Monteduro, Giovanni Tondini, et al.
Frontiers in Immunology|March 27, 2020
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory DiseasesMartina Bonacini, Alessandra Soriano, Luca Cimino, et al.
The British Journal of Ophthalmology|November 21, 2019
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimensAlessandro Invernizzi, Francesco Pichi, Richard Symes, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Ocular Immunology and Inflammation|April 2, 2026
Placoid Macular Lesion as an Atypical Presentation of Vitreoretinal Lymphoma Mimicking Autoimmune RetinopathyRocco Bruno, Fabrizio Gozzi, Emanuele Ragusa, et al.
American Journal of Ophthalmology|April 3, 2026
Unilateral Retinal Pigment Epithelium Dysgenesis (URPED) - The Expanded Spectrum and New Insights from Multimodal ImagingAndrea Trinco, Francesco Romano, Martina Matteucci, et al.
Chembiochem : a European Journal of Chemical Biology|March 31, 2025
Cold-Adapted Lipid A from Polaribacter sp. SM1127: A Study of Structural Heterogeneity and Immunostimulatory PropertiesRoberta Cirella, Emanuela Andretta, Luca De Simone Carone, et al.
Ocular Immunology and Inflammation|April 22, 2024
Anterior Vitreous Objective Assessment in Uveitis: An Anterior Segment Swept Source Optical Coherence Tomography StudyAlessandro Invernizzi, Chiara Zaffalon, Priscilla Manni, et al.
Ocular Immunology and Inflammation|October 6, 2020
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical FeaturesLuca De Simone, Alessandro Invernizzi, Raffaella Aldigeri, et al.
Ocular Immunology and Inflammation|April 1, 2021
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive TreatmentElena Bolletta, Fabrizio Gozzi, Valentina Mastrofilippo, et al.
Journal of Clinical Medicine|December 24, 2021
Uveitis and Other Ocular Complications Following COVID-19 VaccinationElena Bolletta, Danilo Iannetta, Valentina Mastrofilippo, et al.
American Journal of Ophthalmology|January 15, 2024
Immunomodulatory Treatment Versus Systemic Steroids in Inflammatory Choroidal Neovascularization Secondary to Idiopathic Multifocal ChoroiditisMatteo Airaldi, Davide Monteduro, Giovanni Tondini, et al.
Frontiers in Immunology|March 27, 2020
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory DiseasesMartina Bonacini, Alessandra Soriano, Luca Cimino, et al.
The British Journal of Ophthalmology|November 21, 2019
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimensAlessandro Invernizzi, Francesco Pichi, Richard Symes, et al.
Pageof 6